On October 15, 2026, U.K. drugmaker AstraZeneca announced a partnership with artificial intelligence startup Insitro to discover new treatments for cardiometabolic diseases

AI

Artificial intelligence research, products, and impact across society.

12 debates·11,642 claims·218 news stories